Engineered electrical conduction tract restores conduction in complete heart block: from in vitro to in vivo proof of concept.

[1]  Peter Kohl,et al.  Fibroblast–myocyte electrotonic coupling: Does it occur in native cardiac tissue?☆ , 2014, Journal of molecular and cellular cardiology.

[2]  Hubert Cochet,et al.  Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. , 2014, Journal of the American College of Cardiology.

[3]  Luca Segreti,et al.  Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.

[4]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[5]  Hee Cheol Cho,et al.  Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18 , 2012, Nature Biotechnology.

[6]  Peter Kohl,et al.  Mechano-sensitivity of cardiac pacemaker function: Pathophysiological relevance, experimental implications, and conceptual integration with other mechanisms of rhythmicity , 2012, Progress in biophysics and molecular biology.

[7]  J. Morgan,et al.  Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. , 2012, American journal of physiology. Heart and circulatory physiology.

[8]  N. Bursac,et al.  Functional cardiac tissue engineering. , 2012, Regenerative medicine.

[9]  Henggui Zhang,et al.  Anatomical and molecular mapping of the left and right ventricular His-Purkinje conduction networks. , 2011, Journal of molecular and cellular cardiology.

[10]  Robert D. Kirkton,et al.  Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. , 2011, Nature communications.

[11]  Douglas B. Cowan,et al.  Implantation of engineered tissue in the rat heart. , 2009, Journal of visualized experiments : JoVE.

[12]  Lars Eckardt,et al.  Catheter Ablation of Ventricular Tachycardia , 2009, Herz Kardiovaskuläre Erkrankungen.

[13]  Leslie Tung,et al.  IK1 Heterogeneity Affects Genesis and Stability of Spiral Waves in Cardiac Myocyte Monolayers , 2009, Circulation research.

[14]  Frédéric Sacher,et al.  Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years , 2008, Circulation. Arrhythmia and electrophysiology.

[15]  M. Field,et al.  Ventricular Tachycardia AblationCLINICAL PERSPECTIVE , 2008 .

[16]  E. Marbán,et al.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. , 2008, Heart rhythm.

[17]  R Langer,et al.  Biomimetic approach to cardiac tissue engineering , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[18]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[19]  E. McNally,et al.  Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. , 2007, Trends in cardiovascular medicine.

[20]  Thomas Jue,et al.  Myoglobin translational diffusion in rat myocardium and its implication on intracellular oxygen transport , 2007, The Journal of physiology.

[21]  P. D. del Nido,et al.  Cardiac conduction through engineered tissue. , 2006, The American journal of pathology.

[22]  H. Wellens.  When to Perform Catheter Ablation in Asymptomatic Patients With a Wolff-Parkinson-White Electrocardiogram , 2005, Circulation.

[23]  P. Aadahl,et al.  Gut luminal microdialysis of glycerol as a marker of intestinal ischemic injury and recovery , 2005, Critical care medicine.

[24]  Ian E. Alexander,et al.  Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling , 2005, Circulation.

[25]  Randall J Lee,et al.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.

[26]  I. LeGrice,et al.  Fibroblast Network in Rabbit Sinoatrial Node: Structural and Functional Identification of Homogeneous and Heterogeneous Cell Coupling , 2004, Circulation research.

[27]  M. Wheeler,et al.  Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. , 2004, The Journal of clinical investigation.

[28]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[29]  M. Biel,et al.  Dominant-Negative Suppression of HCN Channels Markedly Reduces the Native Pacemaker Current If and Undermines Spontaneous Beating of Neonatal Cardiomyocytes , 2003, Circulation.

[30]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[31]  Mark E. Josephson,et al.  Clinical cardiac electrophysiology ; techniques and interpretations , 2001 .

[32]  E. McNally,et al.  Sarcoglycans in muscular dystrophy , 2000, Microscopy research and technique.

[33]  J. Saffitz,et al.  Rapid turnover of connexin43 in the adult rat heart. , 1998, Circulation research.

[34]  R. Wollmann,et al.  γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.

[35]  D. Grant,et al.  VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. , 1998, Experimental cell research.

[36]  L. Kunkel,et al.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. , 1996, American journal of human genetics.

[37]  D. Goodenough,et al.  Five-hour half-life of mouse liver gap-junction protein , 1981, The Journal of cell biology.

[38]  A. Tonkin,et al.  Initial Forces of Ventricular Depolarization in the Wolff-Parkinson-White Syndrome: Analysis Based upon Localization of the Accessory Pathway by Epicardial Mapping , 1975, Circulation.

[39]  R. Zak.  Development and Proliferative Capacity of Cardiac Muscle Cells , 1974, Circulation research.

[40]  S. Halbert,et al.  IN VITRO ORGANIZATION OF DISSOCIATED RAT CARDIAC CELLS INTO BEATING THREE-DIMENSIONAL STRUCTURES , 1971, The Journal of experimental medicine.

[41]  R. Massini,et al.  [Electrocardiographic aspects of intermittent atrio-ventricular block in the phase of sinus rhythm]. , 1969, Cardiologia pratica.

[42]  J. D. B. MACDOUGALL,et al.  Diffusion Coefficient of Oxygen through Tissues , 1967, Nature.

[43]  T. Starzl,et al.  FAILURE OF SINO-ATRIAL NODAL TRANSPLANTATION FOR THE TREATMENT OF EXPERIMENTAL COMPLETE HEART BLOCK IN DOGS. , 1963, The Journal of thoracic and cardiovascular surgery.

[44]  A Krogh,et al.  The rate of diffusion of gases through animal tissues, with some remarks on the coefficient of invasion , 1919, The Journal of physiology.

[45]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[46]  P. Camelliti,et al.  Structural and functional coupling of cardiac myocytes and fibroblasts. , 2006, Advances in cardiology.

[47]  Byung-Ho Choi,et al.  Autologous fibrin glue in peripheral nerve regeneration in vivo , 2005, Microsurgery.

[48]  A. Moorman,et al.  The development of the atrioventricular junction in the human heart. , 1996, Circulation research.

[49]  A. Nag,et al.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. , 1980, Cytobios.

[50]  Nag Ac,et al.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. , 1980 .